Balchem Corp

Common Name
Balchem
Country
United States
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
1,364
Ticker
BCPC
Exchange
NASDAQ/NGS
Description
Balchem Corporation is a leading producer of specialty performance ingredients and products for the health and wellness sectors. The company specializes in microencapsulation, chelated minerals, and a...

Financial Statements of Balchem

Below are the financial statements of Balchem, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of USD20242023
Current assets
Cash and cash equivalents
49.52a
64.45a
Accounts receivable, net of allowance for credit losses of $909 and $908 at December 31, 2024 and 2023, respectively
119.66a
125.28a
Inventories, net
130.8a
109.52a
Prepaid expenses
8.05a
7.8a
Other current assets
5.74a
7.19a
Total current assets
313.77a
314.24a
Property, plant and equipment, net
282.15a
276.04a
Goodwill
780.03a
778.91a
Intangible assets with finite lives, net
165.05a
191.21a
Right of use assets - operating leases
15.32a
17.76a
Right of use assets - finance lease
1.73a
2.1a
Other non-current assets
17.32a
16.95a
Total assets
1,575.37a
1,597.21a
Current liabilities
Trade accounts payable
54.75a
55.5a
Accrued expenses
43.75a
40.86a
Accrued compensation and other benefits
22.89a
17.23a
Dividends payable
28.51a
25.72a
Income tax payable
4.47a
4.97a
Operating lease liabilities - current
3.13a
3.95a
Finance lease liabilities - current
0.19a
0.27a
Total current liabilities
157.69a
148.49a
Liabilities and stockholders' equity
Revolving loan
190a
309.57a
Deferred income taxes
43.72a
52.05a
Operating lease liabilities - non-current
12.97a
14.6a
Finance lease liabilities - non-current
1.75a
1.94a
Other long-term obligations
19.34a
16.58a
Total liabilities
425.46a
543.23a
Stockholders' equity
Preferred stock, $25 par value. Authorized 2,000,000 shares; none issued and outstanding
0a
0a
Common stock, $.0667 par value. Authorized 120,000,000 shares; 32,527,244 shares issued and outstanding at December 31, 2024 and 32,254,728 shares issued and outstanding at December 31, 2023, respectively
2.17a
2.15a
Additional paid-in capital
174a
145.65a
Retained earnings
997.49a
897.49a
Accumulated other comprehensive (loss) income
-23.75a
8.69a
Total stockholders' equity
1,149.91a
1,053.98a
Total liabilities and stockholders' equity
1,575.37a
1,597.21a

Verified Sources Behind Balchem’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Balchem’s data sources below and access millions more through our Disclosure Search.

a. Balchem's 10-K 2024
Trace every data point back to Balchem’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?